Modafinil

This page shows anti-doping rule violation data we have registered for Modafinil.

Number of cases in Modafinil Last 10 Years

Modafinil

Modafinil ranks #75 globally among prohibited substances, with 39 registered cases (0.3% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,828 verified cases. USA leads with 18 cases, while Track and field is the most affected sport (15 cases).


Cases of Modafinil by Sport
Top Sport: Track and field

15

Track and field cases

0%

Of all violations

39

Total Modafinil cases
Track and field's share of Modafinil violations 0%
15 of 39

Track and field has the most recorded cases of Modafinil violations globally, with 15 registered cases — 0% of all 39 verified cases.

Cases of Modafinil by Country
Top Country: USA

18

USA cases

46.2%

Of all violations

39

Total Modafinil cases
USA's share of Modafinil violations 46.2%
18 of 39

USA dominates Modafinil violations globally, with 18 registered cases — 46.2% of all 39 verified cases.

Global Substance Ranking

Modafinil ranks #75 of 360 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,379
#2 Methandienone
843
#3 Norandrosterone
787
#4 Testosterone
772
···
#75 Modafinil
38
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 64.1%
25 cases
Female 35.9%
14 cases
Analysis: shows an unusually high proportion of female cases (35.9%) compared to the global average (19.9%), a difference of 16 percentage points. Global average: 80.1% male, 19.9% female
Average Suspension Length
37.6
months
Modafinil
30.2
months
Global average

The average suspension for Modafinil violations is 37.6 months, longer than the global average of 30.2 months.

Modafinil is used to counter excessive sleepiness due to narcolepsy. It stimulates the central nervous system and shares some similarities with amphetamine. It is considered a mild stimulant and is, unlike amphetamine, not associated with euphoric effects at high doses. The risk of development of drug dependence or tolerance of this drug is low, at least in patients without prior history of drug dependence. Modafinil has been classified as a performance enhancing stimulant by WADA since 2004. While several mainstream sleep experts say they doubt the drug has performance enhancing effects, a study from 2004 showed that Modafinil prolongs exercise time to exhaustion while performing at 85 % of VO2max and also reduces the perception of effort required to maintain the threshold (1). Jacobs, I; Bell, DG (2004) "Effects of acute modafinil ingestion on exercise time to exhaustion" Med Sci Sports Exerc 36(6):1078-1082 1. http://en.wikipedia.org/ http://www.fass.se/ Written by International Doping Tests & Management (www.idtm.se) for The Anti-Doping Database This substance was first listed in the IOC doping list on 1 January 2003 as a stimulant.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,828 verified anti-doping rule violations across all sports and all countries, and is updated regularly.